Investor Summary

Founded in 1977 by Jeremy Grantham, Dick Mayo, and Eijk van Otterloo, GMO has established itself as a leading global investment management firm with nearly 50 years of experience. Jeremy Grantham serves as co-founder, long-term investment strategist, and Chairman, bringing pioneering expertise in commercial indexing dating back to 1971 and holding a CBE from the UK. The current leadership team includes CEO Scott Hayward, Asset Allocation Co-Head Ben Inker, and Head of Focused Equity Tom Hancock, who holds a PhD in Computer Science from Harvard. The management team averages over 25 years of industry experience, fostering an environment that values individual contributions and encourages open debate and collaboration. GMO maintains global operations with offices in Boston, Amsterdam, London, Singapore, Sydney, Tokyo, and San Francisco, serving institutional investors, financial intermediaries, and high-net-worth families. The firm requires minimum investments of $5 million and caters to sophisticated clients including pension funds and sovereign wealth funds. GMO's leadership is recognized for academic rigor and practical investment expertise, with Jeremy Grantham being a member of the Academy of Arts and Sciences. The firm's culture emphasizes research-driven decision making and systematic approaches to investment management. GMO has successfully navigated multiple market cycles, demonstrating resilience and adaptability in changing market conditions.

Read More

Fund Strategy

GMO employs a contrarian investment philosophy based on mean reversion principles, taking generally bearish approaches to markets with the belief that assets will ultimately revert to their historical means. The firm emphasizes a valuation-based approach that serves clients' long-term interests through disciplined, research-driven strategies. GMO's methodology combines top-down identification of mispriced asset groups with bottom-up selection using proprietary models that incorporate growth and quality factors. The firm has successfully predicted major market bubbles including the Japanese asset price bubble, dot-com bubble, and 2008 housing crisis. GMO maintains a cautious stance on elevated market valuations, particularly noting concerns when more than 30% of U.S. market capitalization trades above 10 times sales. The investment approach blends systematic analysis across diverse asset classes with a focus on emerging market opportunities and ESG integration. Traditional accounting-based metrics are viewed as increasingly detached from economic reality, requiring more sophisticated analytical approaches. The firm encourages dynamic, valuation-aware strategies to navigate complex investment landscapes while maintaining long-term perspective. GMO's contrarian approach extends to tactical asset allocation decisions based on internal predictions of market direction.

Read More

FUND PERFORMANCE AS OF 31st March 2026

ANNUALIZED SINCE INCEPTION QUARTERLY YTD
- - -